Missing: Biotrend's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Biotrend's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Biotrend News
Oct 26, 2022
Biotrend Energy plans to build Turkey’s first commercialized waste plastics recycling facility using Honeywell’s UpCycle Process Technology to convert waste plastics into recycled polymer feedstock· The plant will be able to convert mixed waste plastics into recycled polymer feedstock Honeywell today announced that Biotrend Energy (Borsa Istanbul: BIOEN) will apply Honeywell’s UpCycle Process Technology in Biotrend Energy’s planned plastics recycling factory in Turkey. The facility will convert mixed waste plastics into recycled polymer feedstock (RPF), enabling the development of a circular economy for plastics. When completed, it will become the first commercialized waste plastics recycling facility in Turkey using Honeywell’s UpCycle Process Technology. The planned advanced recycling plant is expected to have the capacity to transform 30,000 metric tons of mixed waste plastics into Honeywell Recycled Polymer Feedstock per year utilizing Honeywell’s UpCycle Process Technology. Honeywell UOP will provide related engineering and technical services, including startup, commissioning, and technical support services during the plant’s lifetime. This project ushers in collaboration between Honeywell and Biotrend Energy on advanced plastics recycling in Turkey with the intent of the parties to collaborate on multiple, additional waste plastic recycling facilities in the future. "Biotrend Energy is a leading player in the waste management sector in Turkey that is investing in a sustainable circular economy. I have full confidence that we will lead the sector in this field with Honeywell,” said Osman Nuri Vardı, CEO of Biotrend Energy. “Biotrend Energy's experience in waste management, supported by Honeywell’s technology, will contribute to Biotrend Energy’s sustainability efforts.” Currently, Biotrend is only able to recover a low percentage of mechanically recycled materials. Moreover, there are some types of plastic waste that cannot be recycled mechanically due to certain process limitations caused by contamination, colors and additives used in plastic production. Currently, the plastics that cannot be mechanically recycled are either converted into Refuse Derived Fuel (RDF) or stored in landfills. Chemical recycling, like that used in the Honeywell UpCycle Process Technology, can process a wider range of waste plastics, supporting Biotrend’s efforts to increase recovery volumes of circular materials. “Honeywell’s UpCycle Process Technology will help Biotrend Energy tackle the challenge of plastic waste in Turkey,” said Barry Glickman, vice president and general manager, Honeywell Sustainable Technology Solutions. “Turkey will be able to increase the range of plastics that can be recycled, which offers the potential to displace a portion of fossil feedstocks for new plastic production.” Today's announcement expands the UpCycle Process Technology footprint, building on Honeywell's recent announcements in the U.S., Spain, and China. Biotrend Energy is one of the pioneers of the integrated waste management industry in Turkey and processes 4,500,000 tons of waste per year across its 18 facilities (including pre-licenced plants) within Turkey. Biotrend Energy’s activities include waste transfer, recycling, landfill, waste to energy and production of organic fertilizer (compost) and RDF. Honeywell’s UpCycle Process Technology is a ready-now technology that utilizes industry-leading molecular conversion, pyrolysis, and contaminants management technology to convert waste plastic to RPF, which is then used to create new plastics. The UpCycle Process Technology expands the types of plastics that can be recycled to include waste plastic that would otherwise go unrecycled, including colored, flexible, multilayered packaging, and polystyrene. Honeywell is committed to achieving carbon neutrality in its operations and facilities by 2035. This commitment builds on the company’s track record of sharply reducing the greenhouse gas intensity of its operations and facilities as well as its decades-long history of innovation to help its customers meet their environmental and social goals. Approximately 60 percent of Honeywell’s new product introduction research and development investment is directed towards products that improve environmental and social outcomes for customers. Source: Honeywell International Inc.
Biotrend Frequently Asked Questions (FAQ)
When was Biotrend founded?
Biotrend was founded in 2000.
Where is Biotrend's headquarters?
Biotrend's headquarters is located at Biocant Park, Cantanhede.
What is Biotrend's latest funding round?
Biotrend's latest funding round is Other Investors.
Who are the investors of Biotrend?
Investors of Biotrend include Sociedade de Investimento, PME Investimentos, Portugal Ventures and InovCapital.
Who are Biotrend's competitors?
Competitors of Biotrend include Pharmaron, WuXi AppTec, Advion Bioanalytical Labs, Inbiopro, Pacific Data Designs and 11 more.
Compare Biotrend to Competitors
Sai Life Sciences offers their clients a wide range of integrated drug discovery, development and formulation services, with core expertise founded in synthetic, medicinal and process chemistry and further augmented by a suite of preclinical support services including DMPK, toxicology and formulation that are continually expanding to meet clients' needs.
Micromyx is a microbiology services company engaged in anti-infective discovery and development for the pharmaceutical, biotechnology, and animal health industries. Founded in 2004 by former pharmaceutical industry infectious disease scientists, Micromyx is a contract research organization that aims to offer clients documented, top-of-the-line laboratory services from experts who have successfully gained FDA approval of new antibiotics.
Bi-Biomics is a life science research and development company based in Nampa, Idaho. The company have many exciting areas of research that start in the basics of cellular biology. The company offer specially formulated histology reagents for tissue preparation and processing. It is the company's intent to bring standardization to the field of histology and usher in a new level of scientifically verifiable methodologies.
Genoway (EPA:ALGEN) is a healthcare research tool developer.
ClinOps, LLC, is a focused contract research organization serving the Biotechnology, Pharmaceutical and Medical Device industries and specializes in data management, SAS/statistical analysis services, and investigatorinitiated study management. The company are committed to being a bestinclass partner to the company's clients by using the company's unparalleled core competencies to advance and accelerate their therapeutic clinical development initiatives.
Renovo Research is a contract research lab that specializes in crystal form discovery for the pharmaceutical industry.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.